| |
 |
|
Class Information
Number: 514/4
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai > Insulin or derivative > With an additional active ingredient
Description: Subject matter which contains insulin and an additional active ingredient.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5273966 |
O-glycosylated IGF-1 |
Dec. 28, 1993 |
| 5273965 |
Methods for enhancing drug delivery with modified saponins |
Dec. 28, 1993 |
| 5266560 |
Pharmaceutical insulin-potentiating CR(III) complexes with GTF-like activity |
Nov. 30, 1993 |
| 5227369 |
Compositions and methods for inhibiting leukocyte adhesion to CNS myelin |
Jul. 13, 1993 |
| 5212154 |
Preparation for treating complications in diabetes |
May. 18, 1993 |
| 5204325 |
Viscoelastic solution |
Apr. 20, 1993 |
| 5200393 |
Lipid excipient for nasal delivery and topical application |
Apr. 6, 1993 |
| 5192741 |
Sustained and controlled release of water insoluble polypeptides |
Mar. 9, 1993 |
| 5179079 |
Nasal formulation and intranasal administration therewith |
Jan. 12, 1993 |
| 5177058 |
Pharmaceutical formulation for the treatment of diabetes mellitus |
Jan. 5, 1993 |
| 5175145 |
Treatment of diabetes mellitus with amylin agonists |
Dec. 29, 1992 |
| 5157021 |
Insulin derivatives and pharmaceutical preparations containing these derivatives |
Oct. 20, 1992 |
| 5155096 |
Method for potentiation of a therapeutic agent |
Oct. 13, 1992 |
| 5149636 |
Method for introducing cloned, amplifiable genes into eucaryotic cells and for producing proteinaceous products |
Sep. 22, 1992 |
| 5149716 |
Insulin derivatives, process for their preparation, their use and a pharmaceutical preparation containing them |
Sep. 22, 1992 |
| 5126324 |
Method of enhancing growth in patients using combination therapy |
Jun. 30, 1992 |
| 5124315 |
Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient |
Jun. 23, 1992 |
| 5124314 |
Pharmaceutical compositions containing amylin |
Jun. 23, 1992 |
| 5122368 |
Anthracycline conjugates having a novel linker and methods for their production |
Jun. 16, 1992 |
| 5112804 |
Pharmaceutical composition and method of intranasal administration |
May. 12, 1992 |
| 5110595 |
Implant preparations containing bioactive macromolecule for sustained delivery |
May. 5, 1992 |
| 5100670 |
Use of a bacitracin fraction as a growth promoting agent |
Mar. 31, 1992 |
| 5093317 |
Treating disorders by application of insulin-like growth factor |
Mar. 3, 1992 |
| 5068220 |
Biodegradable polyamides for providing a controlled release therapeutic drug |
Nov. 26, 1991 |
| 5068224 |
Method of improving regeneration of transfected peripheral nerves using IGF-1 |
Nov. 26, 1991 |
| 5053389 |
Insulin preparation for non-parenteral administration |
Oct. 1, 1991 |
| 5049545 |
Insulin derivatives, a process for their preparation, and their use |
Sep. 17, 1991 |
| 5028587 |
Mixed crystals of insulin and insulin derivatives |
Jul. 2, 1991 |
| 5013714 |
Viscoelastic solution |
May. 7, 1991 |
| 5008241 |
Novel insulin peptides |
Apr. 16, 1991 |
| 5002930 |
Protein absorption enhancing agents |
Mar. 26, 1991 |
| 4988675 |
Method for preventing secondary effects |
Jan. 29, 1991 |
| 4971951 |
Insulin potentiation therapy |
Nov. 20, 1990 |
| 4959351 |
Crystal suspensions of insulin derivatives, processes for their preparation and their use |
Sep. 25, 1990 |
| 4948588 |
Percutaneous absorption accelerator and preparation containing same |
Aug. 14, 1990 |
| 4902505 |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
Feb. 20, 1990 |
| 4876242 |
Human insulin-like growth factor analoges with reduced binding to serum carrier proteins and their production in yeast |
Oct. 24, 1989 |
| 4863896 |
Diabetic control by combined insulin forms |
Sep. 5, 1989 |
| 4843062 |
N-acyl-N-napthoylglycines as aldose reductase inhibitors |
Jun. 27, 1989 |
| 4839341 |
Stabilized insulin formulations |
Jun. 13, 1989 |
| 4822821 |
Method for augmenting fetal hemoglobin |
Apr. 18, 1989 |
| 4801575 |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
Jan. 31, 1989 |
| 4798824 |
Perfusate for the preservation of organs |
Jan. 17, 1989 |
| 4789660 |
Insulin administration using methyl and propyl paraben |
Dec. 6, 1988 |
| 4746508 |
Drug administration |
May. 24, 1988 |
| 4743583 |
Sustained release protein compositions and method for making |
May. 10, 1988 |
| 4729989 |
Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts |
Mar. 8, 1988 |
| 4711884 |
Thiazine and thiazepine containing compounds |
Dec. 8, 1987 |
| 4701440 |
Insulin derivatives, processes for their preparation and their use, and pharmaceutical agents for the treatment of diabetes mellitus |
Oct. 20, 1987 |
| 4699897 |
Biologically active peptides structurally related to regions within growth hormones |
Oct. 13, 1987 |
|
|
|
